학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 11건 | 목록 1~20
Academic Journal
Barisa M; Great Ormond Street Institute of Child Health, University College London, London, UK. m.barisa@ucl.ac.uk.; Muller HP; Great Ormond Street Institute of Child Health, University College London, London, UK.; Zappa E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Shah R; Great Ormond Street Institute of Child Health, University College London, London, UK.; Buhl JL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Draper B; Great Ormond Street Institute of Child Health, University College London, London, UK.; Himsworth C; Great Ormond Street Institute of Child Health, University College London, London, UK.; Bowers C; Great Ormond Street Institute of Child Health, University College London, London, UK.; Munnings-Tomes S; Great Ormond Street Institute of Child Health, University College London, London, UK.; Nicolaidou M; Great Ormond Street Institute of Child Health, University College London, London, UK.; Morlando S; Great Ormond Street Institute of Child Health, University College London, London, UK.; Birley K; Great Ormond Street Institute of Child Health, University College London, London, UK.; Leboreiro-Babe C; Great Ormond Street Institute of Child Health, University College London, London, UK.; Vitali A; Great Ormond Street Institute of Child Health, University College London, London, UK.; Privitera L; Great Ormond Street Institute of Child Health, University College London, London, UK.; O'Sullivan K; Great Ormond Street Institute of Child Health, University College London, London, UK.; Greppi A; Great Ormond Street Institute of Child Health, University College London, London, UK.; Buschhaus M; Lumicks, Amsterdam, The Netherlands.; Román MB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; van den Ham F; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; van 't Veld BR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Ferry G; Great Ormond Street Institute of Child Health, University College London, London, UK.; Fisher J; Great Ormond Street Institute of Child Health, University College London, London, UK.; Shome D; Lumicks, Amsterdam, The Netherlands.; Nadafi R; Lumicks, Amsterdam, The Netherlands.; Ansari IH; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.; Reijmers R; Lumicks, Amsterdam, The Netherlands.; Giuliani S; Great Ormond Street Institute of Child Health, University College London, London, UK.; Sondel P; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.; Donovan LK; Great Ormond Street Institute of Child Health, University College London, London, UK.; Chesler L; Cancer Institute, University College London, London, UK.; Jan Molenaar; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Chester K; The Institute of Cancer Research, London, UK.; Wienke J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. j.wienke-4@prinsesmaximacentrum.nl.; Anderson J; Great Ormond Street Institute of Child Health, University College London, London, UK. j.anderson@ucl.ac.uk.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
De Munter S; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Buhl JL; Princess Máxima Center and Oncode Institute, Utrecht, the Netherlands.; De Cock L; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Van Parys A; Orionis Biosciences BV, Ghent, Belgium.; Daneels W; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Department of Hematology, Ghent University Hospital, Ghent, Belgium.; Pascal E; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Deseins L; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Ingels J; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Goetgeluk G; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Jansen H; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Billiet L; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Pille M; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Van Duyse J; VIB Flow Core, VIB Center for Inflammation Research, Ghent, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.; Bonte S; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.; Vandamme N; VIB Single Cell Core, VIB, Ghent-Leuven, Belgium.; Van Dorpe J; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Department of Pathology, Ghent University Hospital, Ghent, Belgium.; Offner F; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Department of Hematology, Ghent University Hospital, Ghent, Belgium.; Leclercq G; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Taghon T; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Depla E; Orionis Biosciences BV, Ghent, Belgium.; Tavernier J; Orionis Biosciences BV, Ghent, Belgium.; Kerre T; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Department of Hematology, Ghent University Hospital, Ghent, Belgium.; Drost J; Princess Máxima Center and Oncode Institute, Utrecht, the Netherlands.; Vandekerckhove B; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; GMP Unit cell Therapy, Ghent University Hospital, Ghent, Belgium.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Academic Journal
Cornel AM; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; van der Sman L; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; van Dinter JT; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Arrabito M; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Center of Pediatric Hematology & Oncology, University of Catania, Catania, Italy.; Dunnebach E; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; van Hoesel M; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Kluiver TA; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Lopes AP; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Dautzenberg NMM; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Dekker L; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; van Rijn JM; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; van den Beemt DAMH; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Buhl JL; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; du Chatinier A; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Barneh F; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Lu Y; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Lo Nigro L; Center of Pediatric Hematology & Oncology, University of Catania, Catania, Italy.; Krippner-Heidenreich A; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Sebestyén Z; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Kuball J; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Department of Hematology, UMC Utrecht, Utrecht, The Netherlands.; Hulleman E; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Drost J; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; van Heesch S; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Heidenreich OT; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Peng WC; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Nierkens S; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands S.Nierkens-2@prinsesmaximacentrum.nl.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Paassen I; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Williams J; Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.; Ríos Arceo C; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Ringnalda F; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Mercer KS; Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.; Buhl JL; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Moreno N; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.; Federico A; Hopp Children's Cancer Center (KiTZ), 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center DKFZ and German Cancer Consortium DKTK, 69120, Heidelberg, Germany.; Franke NE; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Kranendonk M; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Upadhyaya SA; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.; Kerl K; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.; van de Wetering M; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Clevers H; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center, 3584 CT, Utrecht, the Netherlands.; Pharma, Research and Early Development (pRED) of F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Kool M; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Hopp Children's Cancer Center (KiTZ), 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center DKFZ and German Cancer Consortium DKTK, 69120, Heidelberg, Germany.; Hoving EW; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; Roussel MF; Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.; Drost J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands. J.Drost@prinsesmaximacentrum.nl.; Oncode Institute, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands. J.Drost@prinsesmaximacentrum.nl.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Academic Journal
Usta D; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Sigaud R; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Buhl JL; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Selt F; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Marquardt V; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Germany, and Department of Pediatric Neuro-Oncogenomics, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Pauck D; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Germany, and Department of Pediatric Neuro-Oncogenomics, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Jansen J; Institute of Molecular Medicine and Cell Research (IMMZ), Faculty of Medicine, University of Freiburg, Freiburg, Germany, Centre for Biological Signalling Studies BIOSS, University of Freiburg, Comprehensive Cancer Center Freiburg (CCCF) and German Consortium for Translational Cancer Research (DKTK), Freiburg, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Pusch S; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Ecker J; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Vollmer J; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Sommerkamp AC; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Rubner T; Flow Cytometry Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hargrave D; Neurooncology and Experimental Therapeutics, Great Ormond Street Hospital for Children, London, United Kingdom.; van Tilburg CM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Remke M; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Germany, and Department of Pediatric Neuro-Oncogenomics, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Brummer T; Institute of Molecular Medicine and Cell Research (IMMZ), Faculty of Medicine, University of Freiburg, Freiburg, Germany, Centre for Biological Signalling Studies BIOSS, University of Freiburg, Comprehensive Cancer Center Freiburg (CCCF) and German Consortium for Translational Cancer Research (DKTK), Freiburg, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Milde T; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany. t.milde@kitz-heidelberg.de.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
van Tilburg CM; KiTZ Clinical Trial Unit, Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Milde T; KiTZ Clinical Trial Unit, Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Witt R; KiTZ Clinical Trial Unit, Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Ecker J; KiTZ Clinical Trial Unit, Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Seitz A; Division of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.; Schenk JP; Division of Pediatric Radiology, Heidelberg University Hospital, Heidelberg, Germany.; Buhl JL; KiTZ Clinical Trial Unit, Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Riehl D; DKTK Immune Monitoring Unit, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Frühwald MC; Swabian Children's Cancer Center, University Children's Hospital Augsburg, Augsburg, Germany.; Pekrun A; Children's Hospital, Bremen, Germany.; Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany.; Wieland R; Department of Pediatric Oncology and Hematology, Essen University Hospital, Essen, Germany.; Flotho C; Division of Pediatric Oncology and Hematology, Freiburg University Hospital, Freiburg, Germany.; Kordes U; Department of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany.; Gruhn B; Department of Pediatrics, Jena University Hospital, Jena, Germany.; Simon T; Department of Pediatric Oncology and Hematology, Cologne University Hospital, Cologne, Germany.; Linderkamp C; Department of Pediatric Oncology and Hematology, Hannover University Hospital, Hanover, Germany.; Sahm F; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Taylor L; Pharmacy Department, Heidelberg University Hospital, Heidelberg, Germany.; Freitag A; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Burhenne J; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.; Foerster KI; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.; Meid AD; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.; Pfister SM; KiTZ Clinical Trial Unit, Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Karapanagiotou-Schenkel I; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Witt O; KiTZ Clinical Trial Unit, Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany. o.witt@kitz-heidelberg.de.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany. o.witt@kitz-heidelberg.de.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany. o.witt@kitz-heidelberg.de.
Publisher: Biomed Central Country of Publication: Germany NLM ID: 101516977 Publication Model: Electronic Cited Medium: Internet ISSN: 1868-7083 (Electronic) Linking ISSN: 18687075 NLM ISO Abbreviation: Clin Epigenetics Subsets: MEDLINE
Academic Journal
Buhl JL; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Selt F; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Guiho R; Developmental Biology and Cancer Programme, Birth Defects Research Centre, Great Ormond Street Institute of Child Health, University College London, London, UK.; Ecker J; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Sahm F; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Ridinger J; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Riehl D; Immune Monitoring Unit, DKFZ/NCT, Heidelberg, Germany.; Usta D; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Ismer B; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Pediatric Glioma Research Group, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Sommerkamp AC; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Pediatric Glioma Research Group, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Martinez-Barbera JP; Developmental Biology and Cancer Programme, Birth Defects Research Centre, Great Ormond Street Institute of Child Health, University College London, London, UK.; Wefers AK; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Remke M; Department of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.; Picard D; Department of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.; Pusch S; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Gronych J; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Oehme I; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; van Tilburg CM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Kool M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Kuhn D; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Capper D; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neuropathology, Berlin, Germany.; von Deimling A; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Schuhmann MU; Division of Pediatric Neurosurgery, Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany.; Herold-Mende C; Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.; Korshunov A; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Brummer T; Institute of Molecular Medicine and Cell Research (IMMZ), Faculty of Medicine, University of Freiburg, Freiburg, Germany, Centre for Biological Signalling Studies BIOSS, University of Freiburg and German Consortium for Translational Cancer Research (DKTK), Freiburg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Pediatric Glioma Research Group, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Milde T; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany. t.milde@kitz-heidelberg.de.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Buhl, Juliane L
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어